{"id":"W4387015031","doi":"10.1016/j.jaad.2023.07.093","title":"43758 Bimekizumab safety and tolerability in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in five phase 3/3b clinical trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"UCB Pharma","keywords":"Medicine; Plaque psoriasis; Tolerability; Psoriasis; Clinical trial; Pooled analysis; Safety profile; Dermatology; Adverse effect; Internal medicine; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01276894,0.001604429,0.006681499,0.0008831199,0.000420802,0.001954308,0.0007313779,0.001386467,0.001491615],"category_scores_gemma":[0.006072305,0.0007465008,0.01058983,0.001398803,0.0006723397,0.001405593,0.0007409913,0.002154297,0.0002536536],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007364288,"about_ca_system_score_gemma":0.0008518213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007138004,"about_ca_topic_score_gemma":0.001509967,"domain_scores_codex":[0.9953027,0.002649129,0.0004618114,0.000686987,0.0005330009,0.0003664766],"domain_scores_gemma":[0.9952717,0.002218122,0.001415434,0.000462583,0.0003197895,0.0003123897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.6892977,0.001300084,0.04290993,0.006286351,0.1672063,0.000247794,0.0002419356,0.005311469,0.00656552,0.0001926892,0.00245404,0.07798626],"study_design_scores_gemma":[0.3049696,0.1211965,0.3176635,0.000869185,0.2377044,0.001112757,0.0003504124,0.004648237,0.002793867,0.001072293,0.007294196,0.0003250786],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8922014,0.1002743,0.001902832,0.000353389,0.0002782547,0.000592141,0.002310607,0.0001509731,0.001936132],"genre_scores_gemma":[0.988974,0.007428818,0.0005820517,0.0003938556,0.0002038705,0.0002921633,0.001707251,0.00003203485,0.0003859565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01276894,"threshold_uncertainty_score":0.06752944,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07382226389681977,"score_gpt":0.3803119089144869,"score_spread":0.3064896450176671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}